Norbrook Group SWOT Analysis, Competitors & USP

Posted in Pharma and Healthcare, Total Reads: 2180

SWOT analysis of Norbrook Group analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Norbrook Group SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Norbrook Group to benchmark its business & performance as compared to the competitors and industry. Norbrook Group is one of the leading brands in the pharma and healthcare sector. The table below also lists the top Norbrook Group competitors and elaborates Norbrook Group market segmentation, target group, positioning & Unique Selling Proposition (USP).

Norbrook Group SWOT, Competitors, Marketing STP & Brand analysis Table
Norbrook Group Brand Analysis
Parent Company

Norbrook Laboratories Limited

Category

Veterinary Pharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

Leading research and innovation worldwide.

USP

It is the only company in the world which is licenced by the United States Food and Drugs Administration to manufacture sterile injections for veterinary use outside the USA and import them for sale in USA territory

Norbrook Group STP
Segment

Veterinary and animal health injections.

Target Group

Veterinary healthcare professionals

Positioning

Only homegrown British pharmaceutical industry; focus on animal and veterninary health medications.

Norbrook Group SWOT Analysis
Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Norbrook Group. Strengths are:

1. Outstanding manufacturing capabilities

2. Unparalleled knowledge and expertise in regulatory and licensing requirements.

3. Strict adherence at all times to the standards of ‘Safety, Quality and Efficacy’.

4. Entrepreneurial spirit, landmark products

5. The company has over 3000 employees

6. The brand has received several awards and recognised for its services

Weaknesses

Here are the weaknesses in the Norbrook Group SWOT Analysis:

1. Largely dependent on UK’s market for revenue generation
2. Limited presence in emerging markets

Opportunities

Following are the Opportunities in Norbrook Group SWOT Analysis:

1. Partner with other pharmaceuticals for research and expansion purposes.
2. The industry has a huge potential for growth.

Threats

The threats in the SWOT Analysis of Norbrook Group are as mentioned:

1. Stringent drug development guidelines
2. Strict government policies relating to the pharmaceuticals industry
3. Ethical issues related to testing

Norbrook Group Competition
Competitors

Below are the top 3 Norbrook Group competitors:

1. Summit Veterinary Pharmaceuticals

2. Virbac

3. Dechra

The brandguide table above concludes the Norbrook Group SWOT analysis along with its marketing and brand parameters.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Norbrook Group. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.

Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin